Revvity
Kevin Groves has extensive work experience in the field of scientific research and development. Kevin began their career as a Postdoctoral Researcher at Yale University, where they conducted research on synthetic receptors for protein structure modulation. After completing their postdoctoral work, they joined VisEn Medical as a Principal Scientist, focusing on designing and synthesizing near-infrared emitting molecules and developing fluorescent materials for in vivo molecular imaging. In 2010, Kevin joined PerkinElmer as a Senior Principal Scientist, where they continued their research until 2023. Currently, they hold the position of Senior Principal Scientist at Revvity.
Kevin Groves holds a Ph.D. in Organic Chemistry from Columbia University. Kevin also obtained an A.B. in Chemistry from Princeton University. Prior to their undergraduate studies, Kevin attended Princeton High School.
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com